Tumor-associated antigen peptides as anti-metastatic vaccines

    loading  Checking for direct PDF access through Ovid



Cytotoxic T-lymphocytes (CTLs) kill abnormal cells. CTLs recognize major histocompatibility complex class I molecules in complex with peptides derived from relevant antigens. The identification of tumor associated antigen peptides enabled the design of anti-tumor and anti-metastatic vaccines in a murine lung carcinoma.

Related Topics

    loading  Loading Related Articles